Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Meya

Showing results (131-140 of 260) with videos related to

Pageof 26
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV diseaseJayne Ellis, Laura Joan Nsangi, Mohammed Rassool, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 3, 2018
Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomesFiona V Cresswell, Ananta S Bangdiwala, David B Meya, et al.
Frontiers in Immunology|December 28, 2023
Divergent neuroimmune signatures in the cerebrospinal fluid predict differential gender-specific survival among patients with HIV-associated cryptococcal meningitisSamuel Okurut, David R Boulware, Elizabeth Okafor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan AfricaDavid R Boulware, David B Meya, Tracy L Bergemann, et al.
Mycoses|August 29, 2019
Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural TanzaniaAndrew Katende, Gladys Mbwanji, Diana Faini, et al.
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory SyndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Open Forum Infectious Diseases|December 7, 2019
Erratum to: The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015-2017Jayne Ellis, Ananta S Bangdiwala, Fiona V Cresswell, et al.
Infection and Immunity|March 6, 2019
The Mouse Inhalation Model of <i>Cryptococcus neoformans</i> Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential VirulenceLiliane Mukaremera, Tami R McDonald, Judith N Nielsen, et al.
Open Forum Infectious Diseases|August 1, 2024
Baseline C-reactive Protein as a Risk Factor for Cryptococcal Meningitis and Death in HIV-associated Cryptococcal Antigenemia With CrAg Titer as an Effect ModifierCaleb P Skipper, Paul Kirumira, Biyue Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2019
Change in Plasma Cryptococcal Antigen Titer Is Not Associated With Survival Among Human Immunodeficiency Virus-infected Persons Receiving Preemptive Therapy for Asymptomatic Cryptococcal AntigenemiaMatthew F Pullen, Francis Kakooza, Elizabeth Nalintya, et al.
Pageof 26

Showing results (131-140 of 260) with videos related to

Sort By:
Pageof 26
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV diseaseJayne Ellis, Laura Joan Nsangi, Mohammed Rassool, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 3, 2018
Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomesFiona V Cresswell, Ananta S Bangdiwala, David B Meya, et al.
Frontiers in Immunology|December 28, 2023
Divergent neuroimmune signatures in the cerebrospinal fluid predict differential gender-specific survival among patients with HIV-associated cryptococcal meningitisSamuel Okurut, David R Boulware, Elizabeth Okafor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan AfricaDavid R Boulware, David B Meya, Tracy L Bergemann, et al.
Mycoses|August 29, 2019
Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural TanzaniaAndrew Katende, Gladys Mbwanji, Diana Faini, et al.
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory SyndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Open Forum Infectious Diseases|December 7, 2019
Erratum to: The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015-2017Jayne Ellis, Ananta S Bangdiwala, Fiona V Cresswell, et al.
Infection and Immunity|March 6, 2019
The Mouse Inhalation Model of <i>Cryptococcus neoformans</i> Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential VirulenceLiliane Mukaremera, Tami R McDonald, Judith N Nielsen, et al.
Open Forum Infectious Diseases|August 1, 2024
Baseline C-reactive Protein as a Risk Factor for Cryptococcal Meningitis and Death in HIV-associated Cryptococcal Antigenemia With CrAg Titer as an Effect ModifierCaleb P Skipper, Paul Kirumira, Biyue Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2019
Change in Plasma Cryptococcal Antigen Titer Is Not Associated With Survival Among Human Immunodeficiency Virus-infected Persons Receiving Preemptive Therapy for Asymptomatic Cryptococcal AntigenemiaMatthew F Pullen, Francis Kakooza, Elizabeth Nalintya, et al.
Pageof 26